---
title: "Jade Bios prices $150M follow-on offering, 10M shares at $15; nets ~$140.3M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288775020.md"
description: "Jade Bios priced a follow-on public offering of 10 million shares at $15.00 per share, raising approximately $140.3 million in net proceeds. The company has a 30-day option to sell an additional 1.5 million shares. Net proceeds will fund clinical trials, R&D, manufacturing, and general corporate purposes. The transaction is expected to close on June 5, 2026."
datetime: "2026-06-04T21:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288775020.md)
  - [en](https://longbridge.com/en/news/288775020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288775020.md)
---

# Jade Bios prices $150M follow-on offering, 10M shares at $15; nets ~$140.3M

**Jade Bios announced pricing of a 10,000,000-share public offering at $15.00 per share, expected to raise about $140.3 million net.**

**Key Highlights:**

-   Underwriters priced 10,000,000 shares at $15.00 each; gross proceeds $150.0M before fees and expenses.
-   Underwriters to buy shares from the company at $14.10 per share, with customary underwriting terms and indemnities.
-   Company granted a 30-day option for up to 1,500,000 additional shares (15%); net proceeds could reach ~$161.5M if exercised.
-   Net proceeds expected to be approximately $140.3M after discounts, commissions and expenses; closing expected June 5, 2026.
-   Proceeds intended to fund clinical trials, preclinical studies, manufacturing, R&D, capex, working capital and general corporate purposes.

Original SEC Filing: Jade Biosciences, Inc. \[ JBIO \] - 8-K - Jun. 04, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [JBIO.US](https://longbridge.com/en/quote/JBIO.US.md)

## Related News & Research

- [Jade Biosciences Prices $150 Mln Offering Of Shares At $15.00/shr; Stock Down](https://longbridge.com/en/news/288672622.md)
- [Jade reports interim Phase I results of JADE101 for IgAN](https://longbridge.com/en/news/288395063.md)
- [Silver’s Reversal, Stocks’ Target, and AI](https://longbridge.com/en/news/288553208.md)
- [03:54 ETGIGABYTE verbessert die Motherboard-Leistung mit KI-gestützten Technologien](https://longbridge.com/en/news/289290897.md)
- [04:36 ETGIGABYTE perfecciona el rendimiento de las placas base con tecnologías basadas en IA](https://longbridge.com/en/news/289025403.md)